DOACs - advances and limitations in real world

10.1186/s12959-016-0111-3

Saved in:

Bibliographic Details
Main Author:	Lee, L.H
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Review
Published:	2020
Subjects:	antivitamin K apixaban dabigatran edoxaban enoxaparin idarucizumab prothrombin recombinant blood clotting factor 7a rivaroxaban warfarin anticoagulant therapy Asian atrial fibrillation bleeding brain hemorrhage cerebrovascular accident cost effectiveness analysis drug choice drug efficacy drug safety gastrointestinal hemorrhage heart infarction hemodialysis human off label drug use orthopedic surgery partial thromboplastin time patient care prophylaxis prothrombin time Review thrombin time thromboprophylaxis venous thromboembolism
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181339
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-181339
record_format	dspace
spelling	sg-nus-scholar.10635-1813392024-11-11T17:59:44Z DOACs - advances and limitations in real world Lee, L.H DUKE-NUS MEDICAL SCHOOL antivitamin K apixaban dabigatran edoxaban enoxaparin idarucizumab prothrombin recombinant blood clotting factor 7a rivaroxaban warfarin anticoagulant therapy Asian atrial fibrillation bleeding brain hemorrhage cerebrovascular accident cost effectiveness analysis drug choice drug efficacy drug safety gastrointestinal hemorrhage heart infarction hemodialysis human off label drug use orthopedic surgery partial thromboplastin time patient care prophylaxis prothrombin time Review thrombin time thromboprophylaxis venous thromboembolism 10.1186/s12959-016-0111-3 Thrombosis Journal 14 17 2020-10-27T10:37:23Z 2020-10-27T10:37:23Z 2016 Review Lee, L.H (2016). DOACs - advances and limitations in real world. Thrombosis Journal 14 : 17. ScholarBank@NUS Repository. https://doi.org/10.1186/s12959-016-0111-3 14779560 https://scholarbank.nus.edu.sg/handle/10635/181339 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	antivitamin K apixaban dabigatran edoxaban enoxaparin idarucizumab prothrombin recombinant blood clotting factor 7a rivaroxaban warfarin anticoagulant therapy Asian atrial fibrillation bleeding brain hemorrhage cerebrovascular accident cost effectiveness analysis drug choice drug efficacy drug safety gastrointestinal hemorrhage heart infarction hemodialysis human off label drug use orthopedic surgery partial thromboplastin time patient care prophylaxis prothrombin time Review thrombin time thromboprophylaxis venous thromboembolism
spellingShingle	antivitamin K apixaban dabigatran edoxaban enoxaparin idarucizumab prothrombin recombinant blood clotting factor 7a rivaroxaban warfarin anticoagulant therapy Asian atrial fibrillation bleeding brain hemorrhage cerebrovascular accident cost effectiveness analysis drug choice drug efficacy drug safety gastrointestinal hemorrhage heart infarction hemodialysis human off label drug use orthopedic surgery partial thromboplastin time patient care prophylaxis prothrombin time Review thrombin time thromboprophylaxis venous thromboembolism Lee, L.H DOACs - advances and limitations in real world
description	10.1186/s12959-016-0111-3
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Lee, L.H
format	Review
author	Lee, L.H
author_sort	Lee, L.H
title	DOACs - advances and limitations in real world
title_short	DOACs - advances and limitations in real world
title_full	DOACs - advances and limitations in real world
title_fullStr	DOACs - advances and limitations in real world
title_full_unstemmed	DOACs - advances and limitations in real world
title_sort	doacs - advances and limitations in real world
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/181339
_version_	1821201965314473984

DOACs - advances and limitations in real world

Similar Items